James M. Fujitaki
- Molecular Biology
- Epidemiology top 10%
- Infectious Diseases top 10%
- Endocrinology, Diabetes and Metabolism top 5%
- Organic Chemistry
- Co-authors
- Roberts A. SmithMark D. ErionPaul D. van PoeljeErnest BorekBiswendu B. GoswamiOpendra K. SharmaDavid L. LinemeyerSerge H. Boyer
- Topics
- Biochemical and Molecular Research (8 papers)HIV/AIDS drug development and treatment (7 papers)Hepatitis B Virus Studies (6 papers)
- Journals
- Proceedings of the National Academy of SciencesJournal of the American Chemical SocietyHepatology
- Partner nations
- United StatesTaiwan
In The Last Decade
James M. Fujitaki
32 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 95
- Molecular Biology 585
- Epidemiology 267
- Infectious Diseases 238
- Endocrinology, Diabetes and Metabolism 218
- Organic Chemistry 132
Countries citing papers authored by James M. Fujitaki
This map shows the geographic impact of James M. Fujitaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James M. Fujitaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James M. Fujitaki more than expected).
Fields of papers citing papers by James M. Fujitaki
This network shows the impact of papers produced by James M. Fujitaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James M. Fujitaki. The network helps show where James M. Fujitaki may publish in the future.
Co-authorship network of co-authors of James M. Fujitaki
This figure shows the co-authorship network connecting the top 25 collaborators of James M. Fujitaki. A scholar is included among the top collaborators of James M. Fujitaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James M. Fujitaki. James M. Fujitaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 27 | |
| 2 | 55 | |
| 3 | 46 | |
| 4 | 89 | |
| 5 | 1 | |
| 6 | 1 | |
| 7 | 0 | |
| 8 | 4 | |
| 9 | 17 | |
| 10 | 8 | |
| 11 | 93 | |
| 12 | 4 | |
| 13 | 2 | |
| 14 | 9 | |
| 15 | AICA-riboside: direct quantitation in ultrafiltrates of plasma by HPLC during pharmacokinetic studies in man. | 6 |
| 16 | 16 | |
| 17 | 20 | |
| 18 | 71 | |
| 19 | 26 | |
| 20 | 179 |
About James M. Fujitaki
James M. Fujitaki is a scholar working on Physiology, Hepatology and Infectious Diseases, having authored 34 papers that have together received 1.2k indexed citations. Recurring topics across this work include Biochemical and Molecular Research (8 papers), HIV/AIDS drug development and treatment (7 papers) and Hepatitis B Virus Studies (6 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (218 citations), Infectious Diseases (238 citations) and Hepatology (97 citations). James M. Fujitaki has collaborated with scholars based in United States and Taiwan. Frequent co-authors include Roberts A. Smith, Mark D. Erion, Paul D. van Poelje, Ernest Borek, Biswendu B. Goswami, Opendra K. Sharma, David L. Linemeyer, Serge H. Boyer, Ross Dixon and Jinzhao Hou. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.